John Menditto | VP, IR and Corporate Communications |
David Mazzo | CEO |
James Nisco | VP, Finance and Treasury |
Kristen Buck | EVP, Research and Development and Chief Medical Officer |
Steve Brozak | WBB Securities |
Kemp Dolliver | Brookline Capital Markets |
Pete Enderlin | MAZ Partner |
Joe Pantginis | H.C. Wainwright |
Welcome to the Lisata Therapeutics First Quarter 2023 Financial Results and Business Update Conference Call. Currently all participants are in listen-only mode. [Operator Instructions] As a reminder, this call is being recorded today, Tuesday, May 9, 2023.
I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Lisata. Please go ahead, sir.